Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2009

Open Access 01-08-2009 | Research article

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties

Authors: Robert M Bennett, Ronald Friend, Kim D Jones, Rachel Ward, Bobby K Han, Rebecca L Ross

Published in: Arthritis Research & Therapy | Issue 4/2009

Login to get access

Abstract

Introduction

The Fibromyalgia Impact Questionnaire (FIQ) is a commonly used instrument in the evaluation of fibromyalgia (FM) patients. Over the last 18 years, since the publication of the original FIQ, several deficiencies have become apparent and the cumbersome scoring algorithm has been a barrier to widespread clinical use. The aim of this paper is to describe and validate a revised version of the FIQ: the FIQR.

Methods

The FIQR was developed in response to known deficiencies of the FIQ with the help of a patient focus group. The FIQR has the same 3 domains as the FIQ (that is, function, overall impact and symptoms). It differs from the FIQ in having modified function questions and the inclusion of questions on memory, tenderness, balance and environmental sensitivity. All questions are graded on a 0–10 numeric scale. The FIQR was administered online and the results were compared to the same patient's online responses to the 36-Item Short Form Health Survey (SF-36) and the original FIQ.

Results

The FIQR was completed online by 202 FM patients, 51 rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) patients (31 RA and 20 SLE), 11 patients with major depressive disorder (MDD) and 213 healthy controls (HC). The mean total FIQR score was 56.6 ± 19.9 compared to a total FIQ score of 60.6 ± 17.8 (P < 0.03). The total scores of the FIQR and FIQ were closely correlated (r = 0.88, P < 0.001). Each of the 3 domains of the FIQR correlated well with the 3 related FIQ domains (r = 0.69 to 0.88, P < 0.01). The FIQR showed good correlation with comparable domains in the SF-36, with a multiple regression analysis showing that the three FIQR domain scores predicted the 8 SF-36 subscale scores. The FIQR had good discriminant ability between FM and the 3 other groups; total FIQR scores were HC (12.1 ± 11.6), RA/SLE (28.6 ± 21.2) and MDD (17.3 ± 11.8). The patient completion time was 1.3 minutes; scoring took about 1 minute.

Conclusions

The FIQR is an updated version of the FIQ that has good psychometric properties, can be completed in less than 2 minutes and is easy to score. It has scoring characteristics comparable to the original FIQ, making it possible to compare past FIQ results with future FIQR results.
Appendix
Available only for authorised users
Literature
1.
go back to reference Burckhardt CS, Clark BD, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991, 18: 728-733.PubMed Burckhardt CS, Clark BD, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991, 18: 728-733.PubMed
2.
go back to reference Bennett R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005, 23: S154-S162.PubMed Bennett R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005, 23: S154-S162.PubMed
3.
go back to reference Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR: Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol. 2000, 27: 2683-2691.PubMed Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR: Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol. 2000, 27: 2683-2691.PubMed
4.
go back to reference Offenbacher M, Cieza A, Brockow T, Amann E, Kollerits B, Stucki G: Are the contents of treatment outcomes in fibromyalgia trials represented in the International Classification Of Functioning, Disability, and Health?. Clin J Pain. 2007, 23: 691-701. 10.1097/AJP.0b013e318148b93d.CrossRefPubMed Offenbacher M, Cieza A, Brockow T, Amann E, Kollerits B, Stucki G: Are the contents of treatment outcomes in fibromyalgia trials represented in the International Classification Of Functioning, Disability, and Health?. Clin J Pain. 2007, 23: 691-701. 10.1097/AJP.0b013e318148b93d.CrossRefPubMed
5.
go back to reference Prodinger B, Cieza A, Williams DA, Mease P, Boonen A, Kerschan-Schindl K, Fialka-Moser V, Smolen J, Stucki G, Machold K, Stamm T: Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and Health. Arthritis Rheum. 2008, 59: 650-658. 10.1002/art.23559.CrossRefPubMed Prodinger B, Cieza A, Williams DA, Mease P, Boonen A, Kerschan-Schindl K, Fialka-Moser V, Smolen J, Stucki G, Machold K, Stamm T: Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and Health. Arthritis Rheum. 2008, 59: 650-658. 10.1002/art.23559.CrossRefPubMed
6.
go back to reference Iversen MD: Fibromyalgia: The Fibromyalgia Impact Questionnaire (FIQ). Arthritis Rheum. 2003, 49: S210-S213. 10.1002/art.11397.CrossRef Iversen MD: Fibromyalgia: The Fibromyalgia Impact Questionnaire (FIQ). Arthritis Rheum. 2003, 49: S210-S213. 10.1002/art.11397.CrossRef
7.
go back to reference Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon L, Spaeth M, Williams D, Crofford L: Fibromyalgia syndrome. J Rheumatol. 2007, 34: 1415-1425.PubMed Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon L, Spaeth M, Williams D, Crofford L: Fibromyalgia syndrome. J Rheumatol. 2007, 34: 1415-1425.PubMed
8.
go back to reference World Health Organization: International Classification of Functioning, Disability and Health (ICF). 2001, Geneva: World Health Organization World Health Organization: International Classification of Functioning, Disability and Health (ICF). 2001, Geneva: World Health Organization
9.
go back to reference Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007, 8: 27-10.1186/1471-2474-8-27.PubMedCentralCrossRefPubMed Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007, 8: 27-10.1186/1471-2474-8-27.PubMedCentralCrossRefPubMed
10.
go back to reference Hauser W, Zimmer C, Felde E, Kollner V: What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association. Schmerz. 2008, 22: 176-183. 10.1007/s00482-007-0602-z.CrossRefPubMed Hauser W, Zimmer C, Felde E, Kollner V: What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association. Schmerz. 2008, 22: 176-183. 10.1007/s00482-007-0602-z.CrossRefPubMed
11.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam A, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon R: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33: 160-172. 10.1002/art.1780330203.CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam A, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon R: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33: 160-172. 10.1002/art.1780330203.CrossRefPubMed
12.
go back to reference Ware JR, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed Ware JR, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed
13.
go back to reference Hoffman DL, Dukes EM: The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008, 62: 115-126.PubMedCentralCrossRefPubMed Hoffman DL, Dukes EM: The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008, 62: 115-126.PubMedCentralCrossRefPubMed
14.
go back to reference Birtane M, Uzunca K, Taştekin N, Tuna H: The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol. 2007, 26: 679-684. 10.1007/s10067-006-0359-2.CrossRefPubMed Birtane M, Uzunca K, Taştekin N, Tuna H: The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol. 2007, 26: 679-684. 10.1007/s10067-006-0359-2.CrossRefPubMed
15.
go back to reference Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR: Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005, 53: 519-527. 10.1002/art.21319.CrossRefPubMed Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR: Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005, 53: 519-527. 10.1002/art.21319.CrossRefPubMed
16.
go back to reference Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient delphi exercises. Arthritis Rheum. 2008, 59: 952-960. 10.1002/art.23826.CrossRefPubMed Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient delphi exercises. Arthritis Rheum. 2008, 59: 952-960. 10.1002/art.23826.CrossRefPubMed
17.
go back to reference Jones KD, Horak FB, Winters-Stone K, Irvine JM, Bennett RM: Fibromyalgia is associated with impaired balance and falls. J Clin Rheumatol. 2009, 15: 16-21. 10.1097/RHU.0b013e318190f991.PubMedCentralCrossRefPubMed Jones KD, Horak FB, Winters-Stone K, Irvine JM, Bennett RM: Fibromyalgia is associated with impaired balance and falls. J Clin Rheumatol. 2009, 15: 16-21. 10.1097/RHU.0b013e318190f991.PubMedCentralCrossRefPubMed
18.
go back to reference Porter RJ, Gallagher P, Thompson JM, Young AH: Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry. 2003, 182: 214-220. 10.1192/bjp.182.3.214.CrossRefPubMed Porter RJ, Gallagher P, Thompson JM, Young AH: Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry. 2003, 182: 214-220. 10.1192/bjp.182.3.214.CrossRefPubMed
19.
go back to reference Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, Staib LH, Charney DS, Bremner JD: Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry. 2004, 56: 101-112. 10.1016/j.biopsych.2004.04.002.CrossRefPubMed Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, Staib LH, Charney DS, Bremner JD: Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry. 2004, 56: 101-112. 10.1016/j.biopsych.2004.04.002.CrossRefPubMed
20.
go back to reference Hieblinger R, Coenen M, Stucki G, Winkelmann A, Cieza A: Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for chronic widespread pain from the perspective of fibromyalgia patients. Arthritis Res Ther. 2009, 11: R67-10.1186/ar2696.PubMedCentralCrossRefPubMed Hieblinger R, Coenen M, Stucki G, Winkelmann A, Cieza A: Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for chronic widespread pain from the perspective of fibromyalgia patients. Arthritis Res Ther. 2009, 11: R67-10.1186/ar2696.PubMedCentralCrossRefPubMed
21.
go back to reference Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, Yazici Y: Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008, 35: 1550-1558. 10.3899/jrheum.080182.CrossRefPubMed Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, Yazici Y: Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008, 35: 1550-1558. 10.3899/jrheum.080182.CrossRefPubMed
22.
go back to reference Couper MP, Tourangeau R, Conrad FG, Singer E: Evaluating the effectiveness of visual analog scales: a Web Experiment. Social Science Computer Review. 2006, 24: 227-245. 10.1177/0894439305281503.CrossRef Couper MP, Tourangeau R, Conrad FG, Singer E: Evaluating the effectiveness of visual analog scales: a Web Experiment. Social Science Computer Review. 2006, 24: 227-245. 10.1177/0894439305281503.CrossRef
23.
go back to reference Hollen PJ, Gralla RJ, Kris MG, McCoy S, Donaldson GW, Moinpour CM: A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?. Qual Life Res. 2005, 14: 837-847. 10.1007/s11136-004-0833-8.CrossRefPubMed Hollen PJ, Gralla RJ, Kris MG, McCoy S, Donaldson GW, Moinpour CM: A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?. Qual Life Res. 2005, 14: 837-847. 10.1007/s11136-004-0833-8.CrossRefPubMed
24.
go back to reference Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, IMMPACT, et al: Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005, 113: 9-19. 10.1016/j.pain.2004.09.012.CrossRefPubMed Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, IMMPACT, et al: Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005, 113: 9-19. 10.1016/j.pain.2004.09.012.CrossRefPubMed
25.
go back to reference Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB: Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009, 36: 1304-1311. 10.3899/jrheum.081090.CrossRefPubMed Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB: Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009, 36: 1304-1311. 10.3899/jrheum.081090.CrossRefPubMed
Metadata
Title
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Authors
Robert M Bennett
Ronald Friend
Kim D Jones
Rachel Ward
Bobby K Han
Rebecca L Ross
Publication date
01-08-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2783

Other articles of this Issue 4/2009

Arthritis Research & Therapy 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.